Showing results (121-130 of 144) with videos related to
Sort By:
Pageof 15
American Journal of Clinical Dermatology|December 12, 2019
Clinically Meaningful Responses to Dupilumab in Adolescents with Uncontrolled Moderate-to-Severe Atopic Dermatitis: Post-hoc Analyses from a Randomized Clinical TrialAmy S Paller, Ashish Bansal, Eric L Simpson, et al.The Journal of Allergy and Clinical Immunology|September 29, 2024
CERS1 is a biomarker of Staphylococcus aureus abundance and atopic dermatitis severityH Mark Kenney, Takeshi Yoshida, Evgeny Berdyshev, et al.The Journal of Allergy and Clinical Immunology|July 19, 2011
The signal transducer and activator of transcription 6 gene (STAT6) increases the propensity of patients with atopic dermatitis toward disseminated viral skin infectionsMichael D Howell, Peisong Gao, Byung Eui Kim, et al.The Journal of Allergy and Clinical Immunology|April 5, 2011
Human atopic dermatitis complicated by eczema herpeticum is associated with abnormalities in IFN-γ responseDonald Y M Leung, Pei-Song Gao, Dmitry N Grigoryev, et al.The Journal of Allergy and Clinical Immunology. in Practice|August 21, 2022
Dietary Elimination for the Treatment of Atopic Dermatitis: A Systematic Review and Meta-AnalysisPaul Oykhman, Jared Dookie, Husam Al-Rammahy, et al.Journal of the American Academy of Dermatology|July 16, 2016
Efficacy and safety of crisaborole ointment, a novel, nonsteroidal phosphodiesterase 4 (PDE4) inhibitor for the topical treatment of atopic dermatitis (AD) in children and adultsAmy S Paller, Wynnis L Tom, Mark G Lebwohl, et al.The Journal of Allergy and Clinical Immunology. in Practice|January 16, 2021
Dupilumab Improves Asthma and Sinonasal Outcomes in Adults with Moderate to Severe Atopic DermatitisMark Boguniewicz, Lisa A Beck, Lawrence Sher, et al.Pediatric Dermatology|February 21, 2025
Efficacy and Safety of Once-Daily Roflumilast Cream 0.05% in Pediatric Patients Aged 2-5 Years With Mild-to-Moderate Atopic Dermatitis (INTEGUMENT-PED): A Phase 3 Randomized Controlled TrialLawrence F Eichenfield, Rocco Serrao, Vimal H Prajapati, et al.Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|January 6, 2015
Pimecrolimus in atopic dermatitis: consensus on safety and the need to allow use in infantsThomas Luger, Mark Boguniewicz, Warner Carr, et al.The Journal of Allergy and Clinical Immunology|June 14, 2023
Rapid reduction in Staphylococcus aureus in atopic dermatitis subjects following dupilumab treatmentEric L Simpson, Patrick M Schlievert, Takeshi Yoshida, et al.Pageof 15